22157.jpg
Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies Bundle Report 2022: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis
09 août 2022 06h18 HE | Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and...
Global Cancer Immunotherapy Market to Reach $90.53 Billion by 2027
09 août 2022 05h13 HE | Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Immunotherapy Market (2022-2027) by Product, Application, End User, Geography, Competitive Analysis and the Impact of Covid-19 with...
22157.jpg
Global Cancer Therapies Market Analysis Report 2022-2026: Chemotherapy & Targeted Therapy Lead the Global Cancer Therapies Market
05 août 2022 06h08 HE | Research and Markets
Dublin, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The "Cancer Therapies - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Cancer Therapies Market...
Global Biotechnology Market Report (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
02 août 2022 07h38 HE | Research and Markets
Dublin, Aug. 02, 2022 (GLOBE NEWSWIRE) -- The "Biotechnology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
MicrosoftTeams-image (5).png
Myasthenia Gravis Market to Reach US$ 2.4 Bn by 2027, TMR Report
28 juil. 2022 13h30 HE | Transparency Market Research
Wilmington, Delaware, United States, July 28, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: Analysts at TMR estimate the myasthenia gravis market to clip a CAGR of 8% during the...
Dyadic Logo Current.jpg
Dyadic to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
27 juil. 2022 16h30 HE | Dyadic International, Inc.
JUPITER, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
22157.jpg
Claudin 6: An Exceptionally Attractive Target for Drug Discovery and Development
25 juil. 2022 06h53 HE | Research and Markets
Dublin, July 25, 2022 (GLOBE NEWSWIRE) -- The "Claudin 6: A Target Opportunity To Develop Effector-Enhanced Drug Modalities" report has been added to ResearchAndMarkets.com's offering. Claudin 6...
Global Biologics Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
22 juil. 2022 05h33 HE | Research and Markets
Dublin, July 22, 2022 (GLOBE NEWSWIRE) -- The "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
Global T-Cell Immunotherapy Market Report to 2027 - Featuring Atara Biotherapeutics, Autolus and bluebird bio Among Others
21 juil. 2022 07h18 HE | Research and Markets
Dublin, July 21, 2022 (GLOBE NEWSWIRE) -- The "T-Cell Immunotherapy Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global...
Global Bioreactor Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
18 juil. 2022 07h13 HE | Research and Markets
Dublin, July 18, 2022 (GLOBE NEWSWIRE) -- The "Bioreactor Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...